253 related articles for article (PubMed ID: 24952679)
21. IRE1alpha controls cyclin A1 expression and promotes cell proliferation through XBP-1.
Thorpe JA; Schwarze SR
Cell Stress Chaperones; 2010 Sep; 15(5):497-508. PubMed ID: 20013084
[TBL] [Abstract][Full Text] [Related]
22. Targeting the IRE1α-XBP1 branch of the unfolded protein response in human diseases.
Jiang D; Niwa M; Koong AC
Semin Cancer Biol; 2015 Aug; 33():48-56. PubMed ID: 25986851
[TBL] [Abstract][Full Text] [Related]
23. BCL-2 modulates the unfolded protein response by enhancing splicing of X-box binding protein-1.
Chonghaile TN; Gupta S; John M; Szegezdi E; Logue SE; Samali A
Biochem Biophys Res Commun; 2015 Oct; 466(1):40-5. PubMed ID: 26319553
[TBL] [Abstract][Full Text] [Related]
24. TNF potentiates anticancer activity of bortezomib (Velcade) through reduced expression of proteasome subunits and dysregulation of unfolded protein response.
Nowis D; McConnell EJ; Dierlam L; Palamarchuk A; Lass A; Wójcik C
Int J Cancer; 2007 Jul; 121(2):431-41. PubMed ID: 17373661
[TBL] [Abstract][Full Text] [Related]
25. Loss of p53 enhances the function of the endoplasmic reticulum through activation of the IRE1α/XBP1 pathway.
Namba T; Chu K; Kodama R; Byun S; Yoon KW; Hiraki M; Mandinova A; Lee SW
Oncotarget; 2015 Aug; 6(24):19990-20001. PubMed ID: 26254280
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of the unfolded protein response by ricin a-chain enhances its cytotoxicity in mammalian cells.
Wang CT; Jetzt AE; Cheng JS; Cohick WS
Toxins (Basel); 2011 May; 3(5):453-68. PubMed ID: 22069719
[TBL] [Abstract][Full Text] [Related]
27. Targeting the IRE1α/XBP1 Endoplasmic Reticulum Stress Response Pathway in
Zundell JA; Fukumoto T; Lin J; Fatkhudinov N; Nacarelli T; Kossenkov AV; Liu Q; Cassel J; Hu CA; Wu S; Zhang R
Cancer Res; 2021 Oct; 81(20):5325-5335. PubMed ID: 34548333
[TBL] [Abstract][Full Text] [Related]
28. Screening and identification of inhibitors of endoplasmic reticulum stress-induced activation of the IRE1α-XBP1 branch.
Tashiro E
J Antibiot (Tokyo); 2019 Dec; 72(12):899-905. PubMed ID: 31399644
[TBL] [Abstract][Full Text] [Related]
29. Reduced response of IRE1α/Xbp-1 signaling pathway to bortezomib contributes to drug resistance in multiple myeloma cells.
Xu X; Liu J; Huang B; Chen M; Yuan S; Li X; Li J
Tumori; 2017 May; 103(3):261-267. PubMed ID: 27647225
[TBL] [Abstract][Full Text] [Related]
30. HSP72 protects cells from ER stress-induced apoptosis via enhancement of IRE1alpha-XBP1 signaling through a physical interaction.
Gupta S; Deepti A; Deegan S; Lisbona F; Hetz C; Samali A
PLoS Biol; 2010 Jul; 8(7):e1000410. PubMed ID: 20625543
[TBL] [Abstract][Full Text] [Related]
31. Response of myeloma to the proteasome inhibitor bortezomib is correlated with the unfolded protein response regulator XBP-1.
Ling SC; Lau EK; Al-Shabeeb A; Nikolic A; Catalano A; Iland H; Horvath N; Ho PJ; Harrison S; Fleming S; Joshua DE; Allen JD
Haematologica; 2012 Jan; 97(1):64-72. PubMed ID: 21993678
[TBL] [Abstract][Full Text] [Related]
32. Divergent allosteric control of the IRE1α endoribonuclease using kinase inhibitors.
Wang L; Perera BG; Hari SB; Bhhatarai B; Backes BJ; Seeliger MA; Schürer SC; Oakes SA; Papa FR; Maly DJ
Nat Chem Biol; 2012 Dec; 8(12):982-9. PubMed ID: 23086298
[TBL] [Abstract][Full Text] [Related]
33. Endoplasmic reticulum stress-induced IRE1α activation mediates cross-talk of GSK-3β and XBP-1 to regulate inflammatory cytokine production.
Kim S; Joe Y; Kim HJ; Kim YS; Jeong SO; Pae HO; Ryter SW; Surh YJ; Chung HT
J Immunol; 2015 May; 194(9):4498-506. PubMed ID: 25821218
[TBL] [Abstract][Full Text] [Related]
34. Disruption of IRE1α through its kinase domain attenuates multiple myeloma.
Harnoss JM; Le Thomas A; Shemorry A; Marsters SA; Lawrence DA; Lu M; Chen YA; Qing J; Totpal K; Kan D; Segal E; Merchant M; Reichelt M; Ackerly Wallweber H; Wang W; Clark K; Kaufman S; Beresini MH; Laing ST; Sandoval W; Lorenzo M; Wu J; Ly J; De Bruyn T; Heidersbach A; Haley B; Gogineni A; Weimer RM; Lee D; Braun MG; Rudolph J; VanWyngarden MJ; Sherbenou DW; Gomez-Bougie P; Amiot M; Acosta-Alvear D; Walter P; Ashkenazi A
Proc Natl Acad Sci U S A; 2019 Aug; 116(33):16420-16429. PubMed ID: 31371506
[TBL] [Abstract][Full Text] [Related]
35. The molecular mechanisms of XBP-1 gene silencing on IRE1α-TRAF2-ASK1-JNK pathways in oral squamous cell carcinoma under endoplasmic reticulum stress.
Chen H; Yang H; Pan L; Wang W; Liu X; Ren X; Liu Y; Liu W; Zhang Y; Jiang L; Li K; Zhang B; Wang LX
Biomed Pharmacother; 2016 Feb; 77():108-13. PubMed ID: 26796273
[TBL] [Abstract][Full Text] [Related]
36. Exposure to Stearate Activates the IRE1α/XBP-1 Pathway in 3T3-L1 Adipocytes.
Takeda Y; Ishibashi K; Kuroda Y; Atsumi GI
Biol Pharm Bull; 2021; 44(11):1752-1758. PubMed ID: 34719651
[TBL] [Abstract][Full Text] [Related]
37. Cucurbitacin B induces apoptosis by inhibition of the JAK/STAT pathway and potentiates antiproliferative effects of gemcitabine on pancreatic cancer cells.
Thoennissen NH; Iwanski GB; Doan NB; Okamoto R; Lin P; Abbassi S; Song JH; Yin D; Toh M; Xie WD; Said JW; Koeffler HP
Cancer Res; 2009 Jul; 69(14):5876-84. PubMed ID: 19605406
[TBL] [Abstract][Full Text] [Related]
38. A synthetic chalcone, 2'-hydroxy-2,3,5'-trimethoxychalcone triggers unfolded protein response-mediated apoptosis in breast cancer cells.
Lee DH; Jung Jung Y; Koh D; Lim Y; Lee YH; Shin SY
Cancer Lett; 2016 Mar; 372(1):1-9. PubMed ID: 26742460
[TBL] [Abstract][Full Text] [Related]
39. Microarray analysis of nemorosone-induced cytotoxic effects on pancreatic cancer cells reveals activation of the unfolded protein response (UPR).
Holtrup F; Bauer A; Fellenberg K; Hilger RA; Wink M; Hoheisel JD
Br J Pharmacol; 2011 Mar; 162(5):1045-59. PubMed ID: 21091652
[TBL] [Abstract][Full Text] [Related]
40. The proteasome inhibitor bortezomib enhances the activity of docetaxel in orthotopic human pancreatic tumor xenografts.
Nawrocki ST; Sweeney-Gotsch B; Takamori R; McConkey DJ
Mol Cancer Ther; 2004 Jan; 3(1):59-70. PubMed ID: 14749476
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
